NBIX•benzinga•February 21, 2025 at 01:32 PM

Neurocrine Biosciences Authorizes $500M Share Repurchase Program; This New Share Repurchase Authorization Is In Addition To The $300M Accelerated Repurchase Program That Was Announced In October 2024 And Completed In Early February 2025

No summary available.

Read the full article from the original source for complete details and context.

Article published on February 21, 2025 by benzinga